Headshot of Jeffrey Samet
Profiles

Jeffrey H Samet, MD, MA, MPH

Professor, Community Health Sciences - Boston University School of Public Health

(617) 414-7444
jeff.samet@bmc.org
Crosstown Center
View Full Profile at BUMC

Biography

My research has focused on alcohol and drug use, HIV infection and primary medical care with the following specific projects: linkage of alcohol and drug use treatment and primary medical care; addressing alcohol and drug use issues in the primary care setting; the impact of alcohol and drug use in HIV-infected persons; HIV prevention and treatment in Russian substance users; and establishing medical care for HIV-infected persons.

Other Positions

  • Professor, Medicine - Boston University Chobanian & Avedisian School of Medicine
  • Member, Evans Center for Interdisciplinary Biomedical Research - Boston University
  • Faculty, Medicine - Boston University Chobanian & Avedisian School of Medicine

Education

  • Baylor College of Medicine, MD Field of Study: Medicine
  • Boston University, MPH Field of Study: Epidemiology
  • Brandeis University, MA Field of Study: Chemistry
  • Brandeis University, BA

Websites

Publications

  • Published on 11/24/2025

    Bradley KA, Hyun N, Idu A, Yu O, Bobb JF, Wartko PD, Weinstein Z, Matthews AG, McCormack J, Lee AK, Samet JH. Differences in benefits of office based opioid treatment: Secondary analyses across sub-groups in the PROUD randomized controlled implementation trial. Addiction. 2026 Mar; 121(3):629-642. PMID: 41287180.

     Read At: PubMed
  • Published on 11/21/2025

    Rao AV, Ghare SS, Gautam V, Hoffman KL, Petrosino J, So-Armah K, Samet JH, Patts GJ, Cheng DM, Blokhina E, Krupitsky EM, Lioznov D, Zvartau E, McClain CJ, Tindle H, Freiberg MS, Barve SS. Sex differences in beneficial and pathogenic bacteria in People With HIV (PWH) with a history of heavy alcohol drinking. Front Microbiol. 2025; 16:1632949. PMID: 41356481.

     Read At: PubMed
  • Published on 10/15/2025

    Truong V, Kekibiina A, Muyindike W, Gnatienko N, Tsui JI, Emenyonu NI, Cheng DM, Hahn J, Allison O, Bullard MJ, Lunze K, Samet JH. Gabapentin to achieve HIV viral load suppression in people with risky drinking in Mbarara, Uganda: study protocol for a randomized, double-blinded, placebo-controlled trial (GRAIL). Res Sq. 2025 Oct 15. PMID: 41282191.

     Read At: PubMed
  • Published on 10/11/2025

    El-Bassel N, Samet JH, Cheng DM, Freisthler B, John Winhusen T, Walsh SL. Response to the Editor: Re: registration and multiple outcome testing in the HEALing Communities Study by Dennis M. Gorman and Ben G. Fitzpatrick. Int J Drug Policy. 2025 Nov; 145:105029. PMID: 41077014.

     Read At: PubMed
  • Published on 9/26/2025

    Katz R, Fisher T, Singer-Clark T, Soares Iii W, Carpenter J, Schuessler N, Stadler H, Sahovey A, McAlearney AS, Samet JH, Chatterjee A. Creation of a telehealth addiction consultation service at a rural hospital: a case study. Addict Sci Clin Pract. 2025 Sep 26; 20(1):76. PMID: 41013782.

     Read At: PubMed
  • Published on 8/1/2025

    Tsui JI, Bhatraju EP, Hallgren KA, Rhew IC, Samet JH. High-Dose Buprenorphine Treatment in the Setting of Fentanyl. JAMA Netw Open. 2025 Aug 01; 8(8):e2528119. PMID: 40839262.

     Read At: PubMed
  • Published on 7/29/2025

    Guyatt P, Babe G, Gayowsky A, Rosic T, Rodrigues M, Bach P, Perez R, de Oliveira C, Samet JH, Kerkerian G, Hann J, Dionne JC, Ahmed A, Kim D, Nolan S, Thabane L, Samaan Z, Dennis BB. Impact of hepatitis C serostatus on health service utilization for opioid-related harms among individuals prescribed opioid agonist therapy: A longitudinal prospective cohort study. Drug Alcohol Depend Rep. 2025 Sep; 16:100368. PMID: 40837618.

     Read At: PubMed
  • Published on 7/9/2025

    Brown JL, Larochelle MR, Fanucchi LC, Calvert DC, Campbell ANC, Chandler RK, Feaster DJ, Glasgow LM, Gibson EB, Holloway J, Lofwall MR, Mack A, Mack N, Nunes EV, Talbert JC, Tan S, Vandergrift N, Villani J, Asman K, Babakhanlou-Chase H, Bagley SM, Battaglia TA, Blevins D, Bridden C, Cheng DM, Christopher M, Cogan LW, Cunningham CO, Eggleston B, Fareed N, Fernandez S, Freedman DA, Freiermuth CE, Freisthler B, Gilbert L, Hammerslag L, Harris D, Hunt T, Hussain S, Huynh P, Jackson RD, Kauffman EB, Knott C, Knudsen HK, Lefebvre RC, Levin FR, Massatti R, McAlearney AS, Morgan JR, Lopez RM, Lounsbury DW, Newman L, Nickels K, Oga EA, Oller DA, Parran TV, Quinn M, Ramsey KS, Rapkin BD, Salsberry P, Stein M, Taylor JL, Teater J, Walters ST, Zarkin GA, El-Bassel N, Winhusen TJ, Samet JH, Walsh SL. Effects of the Communities That HEAL intervention on initiation, retention, and linkage to medications for opioid use disorder (MOUD): A cluster randomized wait-list controlled trial. Drug Alcohol Depend. 2025 Sep 01; 274:112785. PMID: 40684522.

     Read At: PubMed
  • Published on 7/3/2025

    Tilhou AS, Assoumou SA, Samet JH. Aligning Efforts to Boost Medications for Opioid Use Disorder and Pre-Exposure Prophylaxis for HIV. J Gen Intern Med. 2026 Jan; 41(2):516-520. PMID: 40610667.

     Read At: PubMed
  • Published on 6/1/2025

    Magane KM, Dukes KA, Fielman S, Palfai TP, Regan D, Cheng DM, Lee H, Kraemer KL, Bullard MJ, Chen CA, Samet JH. Oral vs Extended-Release Injectable Naltrexone for Hospitalized Patients With Alcohol Use Disorder: A Randomized Clinical Trial. JAMA Intern Med. 2025 Jun 01; 185(6):635-645. PMID: 40257810.

     Read At: PubMed

View 486 more publications:View Full Profile at BUMC

News & In the Media

View all profiles